George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,669.50
Bid: 1,669.00
Ask: 1,669.50
Change: 16.50 (1.00%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,671.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Health News Summary

Thu, 29th Mar 2018 13:56

Following is a summary of current health news briefs.

Less heart disease, stroke in immigrants than in U.S.-born

People living in the U.S. but born elsewhere may have lowerrisk for heart disease and stroke than their native-bornneighbors, suggests a new study. Foreign-born residents had arange of risks, however. Women from Europe and men from Africaor South America had the lowest stroke rates compared toU.S.-born peers. Heart disease rates were lowest among men andwomen from Asia, the Caribbean, Central America and Mexico andhighest among men from the Indian Subcontinent and Europe.

First women's yoga training center opens doors in Gaza

A small group of Palestinian women in Gaza are stretchingtheir limbs with yoga to help them teach others to cope with thestresses and traumas of living in the embattled territory. TheGaza Strip, which is dominated by the Islamist Hamas faction,has experienced three wars with neighboring Israel in the past11 years.

Happiness 101: Psychology course strikes chord with Yalestudents

The search for life's sweetest but most elusive treasure -happiness - brings nearly 1,200 Yale University undergraduatestwice a week into an enormous hall on the Connecticut school'scampus for its most popular class ever. "Psychology and the GoodLife" is such a hit that one in four undergraduate students atthe Ivy League university is enrolled in the spring semestercourse, said Laurie Santos, the psychology professor who teachesthe class. It is the largest class enrollment size in thehistory of Yale, founded in 1701.

Teva wins reversal of U.S. jury's $235 million GSK drugpatent verdict

A federal judge on Wednesday overturned a U.S. jury'sverdict that required Teva Pharmaceutical Industries Ltdto pay GlaxoSmithKline Plc more than $235million for infringing a patent covering its blood pressure drugCoreg. U.S. District Judge Leonard Stark in Wilmington, Delawareruled that the evidence did not support the jury's finding inJune that Teva sales of a generic version of the drug causeddoctors to infringe GSK's patent.

Childhood cancer survivors may develop heart problems sooner

Adult survivors of childhood cancer have a greater risk ofheart disease and develop risk factors like high blood pressureand elevated cholesterol earlier in life compared to the generalpopulation, a German study suggests. Researchers studied 951adults, ages 23 to 48, who had been diagnosed with cancer whenthey were less than 15 years old. The study team looked at labtests for risk factors for heart disease, and also forconditions like heart failure, stroke and heart attacks. Alongwith the cancer survivors, they studied more than 15,000similar people who didn’t have malignancies as children.

Ireland sets abortion referendum date for May 25

Ireland will hold a referendum on May 25 on whether or notto liberalize its abortion law, the first opportunity in 35years to overhaul one of the world's strictest regimes that haslong divided the once deeply Catholic nation. A complete ban onabortion was only lifted five years ago for cases where themother's life was in danger. That move fueled calls to givevoters under the age of 50 their first say on more comprehensivereform.

Colon cancer screening rates vary widely across U.S.

The proportion of U.S. adults who get recommended coloncancer screenings has never been as high as doctors would like,but a new study suggests that it’s much lower than expected insome pockets of the country. To catch colon cancer early, whenit’s easier to treat and less lethal, physicians typicallyrecommend that adults aged 50 to 75 get screened every 10 yearswith a colonoscopy or annually with fecal tests. Nationwide,only about 67 percent of adults in this age range were currentwith screening, the study found.

FDA working on a 'dozen' policies to boost copycat biotechdrugs

The U.S. Food & Drug Administration is working on around adozen actions to boost use of cheaper versions of expensivebiotech medicines, the head of the agency Scott Gottlieb said onWednesday. The United States has lagged behind Europe in use ofso-called biosimilars, to the frustration of FDA policymakerswho are starting to approve such products but who are seeingother impediments to getting them to consumers.

Listeria class action filed against South Africa's TigerBrands

A class action lawsuit was filed on Thursday against SouthAfrica's Tiger Brands, after one of its food factorieswas linked to a listeria outbreak that has killed 180 peoplesince early 2017, the lawyer running the case said. RichardSpoor, a human rights advocate who previously masterminded amassive class action on behalf of gold miners with silicosis,filed the lawsuit on behalf of families affected by the listeriaoutbreak. The case against Tiger Brands was clear, Spoor said.

Pregnant? Warm weather exercise and hot baths might be okay

Pregnant women who exercise outside on warm days or spend alittle time in a hot bath or sauna may not necessarily raisetheir body temperature enough to cause problems, a researchreview suggests. While most women without health problems cansafely exercise during pregnancy, doctors discourage workouts inhot weather because it can lead to heat stress and dehydration.Physicians also advise women to avoid saunas and hot tubsbecause these activities can raise the body temperature andincrease the risk of birth defects.

More News
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.